Kawa-Mai® – Processed Malt Syrup (Maltose Syrup)

Category:

Product Center

Imported healthy food

Supplier: Takata Pharmaceutical Co., Ltd. of Japan Country of Origin: Japan Packaging: 6 sachets per box, 9 grams per sachet Directions for Consumption: Consume 1 to 3 times daily. The product can be dissolved in warm beverages or mixed with milk, infant formula, and other similar products. It is recommended that children follow the dosage guidelines below: 1–3 years old: 1 sachet to 1⅔ sachets per serving 6 months–1 year old: ⅔ sachet to 1 sachet per serving Under 6 months: ⅓ sachet to ⅔ sachet per serving Category: Imported Food Main Ingredient: Malt Syrup Retail Platforms: KawaMai Mall WeChat Mini Program, Xiaohongshu Shopping Platform

Return to list

Product Description
Product Search
Supplier Introduction
Download Materials

Supplier

Takata Pharmaceutical Co., Ltd. is a renowned Japanese pharmaceutical company specializing in pediatric medicines. The company boasts extensive experience in the R&D, production, and sales of children’s medications and special functional foods, with a long-standing history. It enjoys widespread popularity and high praise from all sectors of Japanese society. Its pediatric medicines and food products have undergone rigorous and in-depth scientific research and verification, and are manufactured using Japan’s advanced technologies and management systems, ensuring both efficacy and safety. As a result, they enjoy an exceptionally high reputation in Japan and have earned the deep trust of both children and their parents.

Product Background

The main ingredient of this syrup is “maltose.” As its name suggests, “maltose” gets its name from the fact that it’s produced by fermenting starch from malt—germinated barley.

The starch used as a raw material for maltose is primarily derived from corn, potatoes, and sweet potatoes. This product is manufactured using ingredients sourced from Kyushu, Japan.

Maltose is also used as a key ingredient in infant constipation remedies. This is because maltose’s slow fermentation action helps improve intestinal motility in infants, promoting smooth bowel movements and ensuring a safe and reliable composition. At the same time, it serves as a nutritional supplement for infants and young children.

This product is a syrup-like infant and child food developed for the market, featuring a sweet taste and easy consumption. It leverages patented technology specifically developed by Takata Pharmaceutical of Japan for pharmaceutical products.

Product Features

The features of this product are as follows:

(1) Made primarily from maltose derived from Japanese ingredients, this is a high-quality food product that babies can consume with peace of mind, containing no added colors or flavors.

(2) This syrup-like food, with a sweet and honey-like flavor, is easy to consume for everyone from infants and toddlers to the elderly, offering a mild sweetness that comes naturally from nature.

(3) Please note that excessive consumption may cause mild gastrointestinal discomfort.

Product Advantages

・Food products made in Japan, derived from natural ingredients and safe for consumption—perfectly suitable for infants and young children.

・High-quality products that can be recommended to families who prioritize their children’s health.

・It can also be used as a small gift from grandparents or close friends and relatives to children.

・Its natural sweetness can be dissolved in warm beverages or consumed together with milk, infant formula, and other similar products.

・This product is packaged in an aluminum foil bag, making it convenient to carry, store, and use. The product has a shelf life of 2 years.

Product Management

Kawa-Mai®—Processed Malt Syrup (Maltose Syrup) by Rico International (Beijing) Medicine Technology Co., Ltd. and Takata Pharmaceutical Co., Ltd. of Japan provide technical support.

Sales price and agency territory: To be negotiated.

Contact Information:

Rico International (Beijing) Medicine Technology Co., Ltd.

Address: Unit 1102B, Building B, East Zone, Jianwai SOHO, No. 39, Middle Section of East Third Ring Road, Chaoyang District, Beijing

Phone: 010-53329998

Contact persons: Ms. Qi, Mr. Feng
Kodak Company Introduction

Since its establishment, Takada Pharmaceutical has adhered to the corporate philosophy of “striving for innovative product development and providing high-quality products at reasonable prices, thereby contributing to people’s health.” As an R&D-driven pharmaceutical company, we are primarily engaged in the research, development, manufacturing, and sales of pharmaceutical products. Takada Corporation was founded in November 1928 (Showa Year 3) with a registered capital of 1.0884 billion yen and currently employs 801 people. We manufacture and sell pharmaceutical products, refreshing beverages, and health foods. In recent years, the healthcare environment has undergone significant changes. Takada Corporation aspires to continue making meaningful contributions to healthcare by developing uniquely innovative, high-value-added products. Moreover, we aim not only to serve the Japanese market but also to deliver even more high-quality pharmaceutical products to customers worldwide. As an R&D-focused enterprise, Takada Corporation is committed to continuously enhancing our technological capabilities, creating original products, and supplying high-quality products at reasonable prices, thus contributing to people’s health. While maintaining a strong social reputation, our company places great importance on both corporate growth and employee well-being, as well as the mutual development of our partners. To become an indispensable and trusted presence among patients, medical professionals, and customers alike, we will keep thriving and continually infusing new vitality into our operations.

At Takada Pharmaceutical, our corporate philosophy is “to contribute to people’s health by developing innovative products and supplying high-quality products appropriately.” As a research-and-development-oriented company, we primarily engage in the research, development, manufacturing, and sale of pharmaceutical products. Founded in November 1928 (Showa 3), the company has a capital of 1.08884 billion yen and employs 801 people. It operates in the fields of pharmaceutical manufacturing and sales, as well as the production of soft drinks and health foods. Today, the environment surrounding healthcare is undergoing profound changes. To contribute in even the smallest way to medical care through our products, we at Takada Pharmaceutical are constantly striving to develop uniquely innovative, high-value-added products that reflect our company’s distinctive character. Moreover, we aspire not only to serve the domestic market but also to support people around the world who are eagerly awaiting high-quality pharmaceuticals. As a research-and-development-oriented company, we will continue to enhance our technological capabilities, create groundbreaking products, and ensure the proper supply of high-quality medications—thereby contributing to people’s health, earning societal trust, and pursuing the advancement of our company, the well-being of our employees, and the mutual prosperity of our partners. We are committed to making even greater efforts to become a trusted, sought-after, and indispensable presence for our patients, healthcare professionals, and business partners alike.

Takata Corporation official website: https://www.takata-seiyaku.co.jp/
References and Literature:

Kawa-Mai®—Processed Malt Syrup (Maltose Syrup) Product Introduction.pdf Size: 137 KB 2024-03-19 15:29:19 Download